−0.16 CNY
−651.76 M CNY
49.32 B CNY
1.80 B
About HUBEI BIOCAUSE PH
Sector
CEO
Wen Xia Zhou
Headquarters
Jingmen
Website
Founded
1993
ISIN
CNE000000F48
FIGI
BBG000P6C9B3
Hubei Biocause Pharmaceutical Co., Ltd. is an investment holding company that engages in the insurance industry. It operates through the following business segments: Life insurance, Health insurance, and Others. The Life insurance segment includes businesses related to the company's life insurance policies, including original insurance contracts and life insurance policies that have not transferred significant insurance risks. The Health insurance segment covers accident, and health insurance policies. The company was founded on November 18, 1993 and is headquartered in Jingmen, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 000627 is 4.67 CNY — it has decreased by −7.34% in the past 24 hours. Watch HUBEI BIOCAUSE PH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HUBEI BIOCAUSE PH stocks are traded under the ticker 000627.
000627 stock has risen by 0.43% compared to the previous week, the month change is a 13.63% rise, over the last year HUBEI BIOCAUSE PH has showed a 64.44% increase.
000627 reached its all-time high on Jun 8, 2015 with the price of 17.30 CNY, and its all-time low was 0.81 CNY and was reached on Jul 19, 2005. View more price dynamics on 000627 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
000627 stock is 8.15% volatile and has beta coefficient of 1.71. Track HUBEI BIOCAUSE PH stock price on the chart and check out the list of the most volatile stocks — is HUBEI BIOCAUSE PH there?
Today HUBEI BIOCAUSE PH has the market capitalization of 24.90 B, it has increased by 7.78% over the last week.
Yes, you can track HUBEI BIOCAUSE PH financials in yearly and quarterly reports right on TradingView.
000627 net income for the last quarter is 31.92 M CNY, while the quarter before that showed −275.15 M CNY of net income which accounts for 111.60% change. Track more HUBEI BIOCAUSE PH financial stats to get the full picture.
As of Dec 31, 2024, the company has 1.76 K employees. See our rating of the largest employees — is HUBEI BIOCAUSE PH on this list?
Like other stocks, 000627 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUBEI BIOCAUSE PH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUBEI BIOCAUSE PH technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUBEI BIOCAUSE PH stock shows the strong buy signal. See more of HUBEI BIOCAUSE PH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.